Valeo Pharma announces Richard J. MacKay as Chairman
19-Jan-2010
- Canada
Mr. MacKay joins Valeo Pharma following his retirement from Stiefel, where he held the positions of Vice-Chairman of the Board of Directors of Stiefel Laboratories, and President of Stiefel Canada. Richard MacKay's experience in building strategic alliances and developing business in the Canadian dermatology market will be of great benefit to Valeo Pharma.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Cornell Lab of Ornithology - Ithaca, USA
Go to page
Arius announces new findings in Trop-2 and CD59 CANCER antibody programs - CD59 antibody uses novel approach to "de-cloak" cancers
Go to page
FluIT Biosystems GmbH - Wendelsheim, Germany
Go to page
Lipid Therapeutics GmbH: - Heidelberg, Germany
Go to page
FRIEDRICHS FILTERSYSTEME GMBH - Wassenberg, Germany
Go to page
Amgen Names Yuji Orihara President, Amgen KK
Go to page
Amgen and Genentech settle patent dispute
Go to page
Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
Go to page
Prednisone
Go to page
Pharma Stulln GmbH - Stulln, Germany
Go to page
FP-Anlagentechnik und Service - Pfofeld, Germany
Go to page
Oswaldo Cruz Foundation and Genzyme Corporation Form Collaboration To Advance New Drugs for Neglected Diseases
Go to page